All updates
All updates
today 32中文产业新闻精选Chinese source评分6565 中文产业新闻精选Chinese source评分6565 礼来塞普替尼片剂在中国获批
EMA News评分4040 Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 14-17 September 2026
中文产业新闻精选Chinese source评分7777 FDA 批准 FAYUVI 用于治疗儿童 MPS IIIA
文献与产业新闻评分3737 First myostatin-targeted antibody approved for spinal muscular atrophy
文献与产业新闻评分1818 Kennedy announces new effort to speed up autism diagnoses
文献与产业新闻评分2626 Kennedy renews attacks on vaccines at Children’s Health Defense conference
中文产业新闻精选Chinese source评分8282 FDA批准Ultragenyx基因疗法Fayuvi上市治疗MPS IIIA
文献与产业新闻评分5757 STAT+: FDA approves a new gene therapy for Sanfilippo syndrome, an ultra-rare disease
文献与产业新闻评分4848 Twelve days to go and pharma tariff rules are a total mystery
文献与产业新闻精选评分6161 FDA approves Ultragenyx’s gene therapy Fayuvi for rare neurodegenerative disorder
文献与产业新闻评分2626 ARPA-H launches SPECTRA program, new autism research initiative
文献与产业新闻评分6060 Kennedy moves to revive preventive services panel with new members, after months of vacancies
FDA Press Releases精选评分7070 FDA Approves First Gene Therapy for Pediatric Patients with Sanfilippo Syndrome Type A
文献与产业新闻评分1616 STAT+: FDA has too few staffers to hire more staff
文献与产业新闻精选评分7373 Bayer’s Kerendia secures FDA nod as first drug in 30 years for Type 1 diabetes-associated kidney disease
文献与产业新闻评分2929 STAT+: The FDA’s rebuilding effort is running into a new challenge
中文产业新闻精选Chinese source评分6262 FDA 批准拜耳非奈利酮用于 1 型糖尿病相关慢性肾病
中文产业新闻精选Chinese source评分6060 拜耳非奈利酮获 FDA 批准用于 1 型糖尿病合并慢性肾脏病
中文产业新闻精选Chinese source评分6969 DB09研究支持德曲妥珠单抗联合帕妥珠单抗一线治疗HER2阳性转移性乳腺癌获NMPA批准
文献与产业新闻评分2929 FDA drops warning letter on Bausch & Lomb, citing contamination concerns
中文产业新闻精选Chinese source评分6363 拜耳塞伐艾替尼获FDA加速批准，用于HER2突变非鳞状NSCLC一线治疗
文献与产业新闻评分5757 STAT+: England to cover AstraZeneca breast cancer drug, a result of U.K.-U.S. drug pricing deal
文献与产业新闻评分4242 New lawsuit argues NIH violated First Amendment rights of grant applicants
文献与产业新闻评分2525 STAT+: GOP aims to change Medicare adviser’s math so it’s more favorable to health insurers
文献与产业新闻评分1818 STAT+: Senators highlight the power Chris Klomp wields at confirmation hearings
文献与产业新闻评分1818 STAT+: Sen. Warren demands to see Trump drug-pricing pharma contracts, accuses RFK Jr. of hiding them
文献与产业新闻评分2020 STAT+: Pharmalittle: We’re reading about faster FDA approvals, access to experimental drugs in Montana, and more
文献与产业新闻评分88 MHRA sets out steps to prevent avoidable harm from patient hoists
中文产业新闻精选Chinese source评分6969 FDA公布加速IND试点最终方案，直指中国和澳大利亚FIH速度差距
中文产业新闻精选Chinese source评分7171 国家医保局试行高水平新技术新产品医疗服务价格预立项制度
中文产业新闻精选Chinese source评分6868 FDA批准泽尼达妥单抗联合方案一线治疗HER2阳性胃食管腺癌
中文产业新闻精选Chinese source评分6161 Curium核药仿制药Bexlutry获FDA批准，系全球首个放射性配体疗法仿制药
中文产业新闻精选Chinese source评分6161 国家医保局试行医疗服务价格项目预立项制度
中文产业新闻精选Chinese source评分6666 国家医保局印发第一批医保医疗服务项目目录制定工作方案
文献与产业新闻评分2929 FDA approves pioneering breast cancer drug that nips resistance in the bud
文献与产业新闻评分5353 FDA fills in blanks on expedited IND pilot
文献与产业新闻精选评分6363 FDA signals tighter scrutiny of early-stage data from China
文献与产业新闻评分3434 STAT+: Medicare to expand its pilot that pays for technology to manage chronic diseases
文献与产业新闻评分4444 STAT+: FDA takes applications for new program to shorten drug approval times